Biosimilar User Fee Amendments

F

FDA

Guest
The Federal Food, Drug, and Cosmetic Act (the FD&C Act), as amended by the Biosimilar User Fee Amendments of 2017 (BsUFA II), authorizes FDA to assess and collect fees for biosimilar biological products from October 2017 through September 2022.


Baca selengkapnya di : http://www.fda.gov...
 
Top